#targeted therapy — Sunday, May 31, 2026 (1 items)
| 0 | 💬 0 |
Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-05-31 | #cancer #clinical trial #lung cancer #targeted therapy |